PREP Repeal Act
repeals liability protections under the PREP Act, enabling lawsuits for injuries from covered countermeasures in public health emergencies.
repeals liability protections under the PREP Act, enabling lawsuits for injuries from covered countermeasures in public health emergencies.
The PREP Repeal Act (HR 4388) was introduced in the House of Representatives on July 15, 2025, by Representative Thomas Massie, with Warren Davidson and Paul A. Gosar as cosponsors. The bill seeks to repeal specific sections of the Public Health Service Act that provide liability immunity to pharmaceutical manufacturers during public health emergencies.
The primary intent of the PREP Repeal Act is to:
- Revoke liability protections that have been granted to pharmaceutical companies under the Public Readiness and Emergency Preparedness Act (PREP Act).
- Restore the ability of individuals to seek legal recourse for injuries or harm resulting from the use of pandemic-related products.
The bill includes several significant provisions:
Repeal of Liability Immunity:
Rescission of Funds:
Preservation of Rights:
Application of the Act:
Severability Clause:
The PREP Repeal Act aims to:
- Enhance Accountability: By removing liability shields, the bill seeks to restore public trust and accountability in the pharmaceutical industry during health emergencies.
- Empower Individuals: It allows citizens to seek justice and compensation for injuries caused by pandemic-related products, reinforcing the principle of due process.
The PREP Repeal Act represents a significant shift in the legal landscape surrounding public health emergencies, aiming to balance the need for rapid response to health crises with the rights of individuals to seek redress for harm. The outcome of this bill could have lasting implications for public health policy and the pharmaceutical industry.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.